These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 14675185)

  • 21. Role of intramolecular epitope spreading in pemphigus vulgaris.
    Salato VK; Hacker-Foegen MK; Lazarova Z; Fairley JA; Lin MS
    Clin Immunol; 2005 Jul; 116(1):54-64. PubMed ID: 15925832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epitope spreading is rarely found in pemphigus vulgaris by large-scale longitudinal study using desmoglein 2-based swapped molecules.
    Ohyama B; Nishifuji K; Chan PT; Kawaguchi A; Yamashita T; Ishii N; Hamada T; Dainichi T; Koga H; Tsuruta D; Amagai M; Hashimoto T
    J Invest Dermatol; 2012 Apr; 132(4):1158-68. PubMed ID: 22277941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining the pathogenic involvement of desmoglein 4 in pemphigus and staphylococcal scalded skin syndrome.
    Nagasaka T; Nishifuji K; Ota T; Whittock NV; Amagai M
    J Clin Invest; 2004 Nov; 114(10):1484-92. PubMed ID: 15545999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunofluorescence and immunoblot studies on the reactivity of pemphigus vulgaris and pemphigus foliaceus sera with desmoglein 3 and desmoglein 1.
    Hashimoto T; Amagai M; Garrod DR; Nishikawa T
    Epithelial Cell Biol; 1995; 4(2):63-9. PubMed ID: 8688919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.
    Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH
    J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
    España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
    Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris.
    Futei Y; Amagai M; Sekiguchi M; Nishifuji K; Fujii Y; Nishikawa T
    J Invest Dermatol; 2000 Nov; 115(5):829-34. PubMed ID: 11069620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Divergent Specificity Development of IgG1 and IgG4 Autoantibodies in Endemic Pemphigus Foliaceus (Fogo Selvagem).
    Maldonado M; Diaz LA; Prisayanh P; Yang J; Qaqish BF; Aoki V; Hans-Filho G; Rivitti EA; Culton DA; Qian Y
    Immunohorizons; 2017 Aug; 1(6):71-80. PubMed ID: 28868524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The plant lectin wheat germ agglutinin inhibits the binding of pemphigus foliaceus autoantibodies to desmoglein 1 in a majority of patients and prevents pathomechanisms of pemphigus foliaceus in vitro and in vivo.
    Ortiz-Urda S; Elbe-Bürger A; Smolle J; Marquart Y; Chudnovsky Y; Ridky TW; Bernstein P; Wolff K; Rappersberger K
    J Immunol; 2003 Dec; 171(11):6244-50. PubMed ID: 14634141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
    Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
    J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display.
    Payne AS; Ishii K; Kacir S; Lin C; Li H; Hanakawa Y; Tsunoda K; Amagai M; Stanley JR; Siegel DL
    J Clin Invest; 2005 Apr; 115(4):888-99. PubMed ID: 15841178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus.
    Futei Y; Amagai M; Hashimoto T; Nishikawa T
    J Am Acad Dermatol; 2003 Dec; 49(6):1023-8. PubMed ID: 14639380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
    Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
    J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-desmoglein 1 antibodies in Tunisian healthy subjects: arguments for the role of environmental factors in the occurrence of Tunisian pemphigus foliaceus.
    Kallel Sellami M; Ben Ayed M; Mouquet H; Drouot L; Zitouni M; Mokni M; Cerruti M; Turki H; Fezza B; Mokhtar I; Ben Osman A; Zahaf A; Kamoun MR; Joly P; Masmoudi H; Makni S; Tron F; Gilbert D
    Clin Exp Immunol; 2004 Jul; 137(1):195-200. PubMed ID: 15196262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction.
    Waschke J; Bruggeman P; Baumgartner W; Zillikens D; Drenckhahn D
    J Clin Invest; 2005 Nov; 115(11):3157-65. PubMed ID: 16211092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity.
    Cirillo N; Gombos F; Lanza A
    J Cell Physiol; 2007 Feb; 210(2):411-6. PubMed ID: 17058228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo analysis of desmoglein 1-responsive T-helper (Th) 1 and Th2 cells in patients with pemphigus foliaceus and healthy individuals.
    Gebhard KL; Veldman CM; Wassmuth R; Schultz E; Schuler G; Hertl M
    Exp Dermatol; 2005 Aug; 14(8):586-92. PubMed ID: 16026580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocytosis of IgG, Desmoglein 1, and Plakoglobin in Pemphigus Foliaceus Patient Skin.
    Oktarina DAM; Sokol E; Kramer D; Jonkman MF; Pas HH
    Front Immunol; 2019; 10():2635. PubMed ID: 31781120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pemphigus foliaceus.
    Dasher D; Rubenstein D; Diaz LA
    Curr Dir Autoimmun; 2008; 10():182-94. PubMed ID: 18460886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune response in pemphigus and beyond: progresses and emerging concepts.
    Di Zenzo G; Amber KT; Sayar BS; Müller EJ; Borradori L
    Semin Immunopathol; 2016 Jan; 38(1):57-74. PubMed ID: 26597100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.